Molecular control of cell cycle progression in the pancreatic β-cell

Endocrine Reviews

Volumn 27, Issue 4, 2006, Pages 356-370

  Cozar Castellano, Irene ^a   Fiaschi Taesch, Nathalie ^a   Bigatel, Todd A ^a   Takane, Karen K ^a   Garcia Ocaña, Adolfo ^a   Vasavada, Rupangi ^a   Stewart, Andrew F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; CYCLIN A; CYCLIN D; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN E; METHIONINE; PROTEIN P53; PROTEIN P57; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR E2F2; TRANSCRIPTION FACTOR E2F4; TRANSCRIPTION FACTOR E2F5; TRANSCRIPTION FACTOR E2F6; VIRUS LARGE T ANTIGEN;

CARCINOGENICITY; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIVISION; CELL FUNCTION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; DIABETES MELLITUS; HUMAN; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INNER CELL MASS; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW;

ANIMALS; ANTIGENS, VIRAL, TUMOR; CELL CYCLE; CYCLIN-DEPENDENT KINASES; CYCLINS; E2F TRANSCRIPTION FACTORS; HUMANS; INSULIN-SECRETING CELLS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 33744920617     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2006-0004     Document Type: Review

References (85)

1. Swenne I 1985 Glucose-stimulated DNA replication in the pancreatic islets during the development of the rat fetus. Diabetes 34:803-807
2. Hanahan D 1985 Heritable formation of pancreatic β-cell tumors in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315:115-122
3. Rane S, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, Barbacid M 1999 Loss of expression of cdk4 causes insulin-deficient diabetes and cdk4 activation results in β-cell hyperplasia. Nat Genet 22:44-52
4. Finegood DT, Scaglia L, Bonner-Weir S 1995 Dynamics of β-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44:249-256
5. Teta M, Long SY, Wartschow LM, Rankin MM, Kushner JA 2005 Very slow turnover of β-cells in aged adult mice. Diabetes 54:2557-2567
6. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC 2003 β-Cell deficit and increased β-cell apoptosis in humans with diabetes. Diabetes 52:102-110
7. Kassem SA, Ariel I, Thornton PS, Scheimberg I, Glaser B 2000 β-Cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. Diabetes 49:1325-1333
8. Garcia-Ocaña A, Vasavada RC, Takane KK, Cebrian A, Lopez-Talavera JC, Stewart AF 2001 Using β-cell growth factors to enhance human pancreatic islet transplantation. J Clin Endocrinol Metab 86:984-988
9. Vasavada RC, Garcia-Ocana A, Takane KK, Cebrian A, Lopez-Talavera J-C, Stewart AF 2003 Islet growth factors. In: Sperlng MA, ed. Type I diabetes: etiology and treatment. Totowa, NJ: Humana Press
10. Vasavada RC, Gonzalez-Pertusa J, Fujinaka Y, Fiaschi-Taesch N, Cozar-Castellano I, Garcia-Ocana A 2006 Growth factors and β-cell replication. Int J Biochem Cell Biol 38:931-950
11. Montana E, Bonner-Weir S, Weir GC 1994 Transplanted β-cell response to increased metabolic demand. Changes in β-cell replication and mass. J Clin Invest 93:1577-1582
12. Dor Y, Brown J, Martinez OI, Melton DA 2004 Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 429:41-46
13. Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A 1999 The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20:501-534
14. Pagano M, Jackson PK 2004 Wagging the dogma: tissue-specific cell cycle control in the mouse embryo. Cell 118:535-538
15. Cam H, Dynlacht D 2003 Emerging roles for E2F: beyond the G1/S transition and DNA replication. Cancer Cell 3:311-316
16. Trimarchi JM, Lees JA 2002 Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3:11-20
17. cip. Diabetes 55:70-77
18. Fajas L, Annicotte J-S, Miard S, Sarruf D, Watanabe M, Auwerx J 2004 Impaired pancreatic growth, β cell mass and β cell function in E2F1-/- mice. J Clin Invest 113:1288-1295
19. Iglesias A, Murga M, Laresgoiti U, Skoudy A, Bernales I, Fullaondo A, Moreno B, Lloreta J, Field SJ, Real FX, Zubiaga AM 2004 Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double mutant mice. J Clin Invest 113:1398-1407
20. Munger K 2005 Clefts, grooves and (small) pockets: the structure of the retinoblastoma tumor suppressor in complex with its cellular target E2F unveiled. Proc Natl Acad Sci USA 100:2165-2167
21. Chau BN, Wang JYJ 2003 Coordinated regulation of life and death by Rb. Nat Rev Cancer 3:130-138
22. Berns A 2003 Timing will tell. Science 424:140-141
23. Hernando E, Nahle Z, Juan G, Diaz-Rodriguez, Alaminos M, Hemann M, Michel L, Mittal V, Gerald W, Benezra R, Lowe SW, Cordon-Cardo C 2004 Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Science 430:797-802
24. Wu L, de Bruin A, Saavedra HI, Starovic M, Trimboli A, Yang Y, Opavska J, Wilson P, Thompson JC, Ostrowski MC, Rosol TJ, Woollett LA, Weinstein M, Cross JC, Robinson M, Leone G 2003 Extra-embryonic function of Rb is essential for embryonic development and viability. Nature 421:942-947
25. 1 control and immortalization. Genes Dev 14:3037-3050
26. Sage J, Miller AL, Perez-Mancera PA, Wysocki JM, Jacks T 2003 Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424:223-227
27. Harvey M, Vogel H, Lee EY-P, Bradley A, Donehower LA 1995 Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 55:1146-1151
28. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T 1994 Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 7:480-484
29. 1. Diabetes 53:149-159
30. Vasavada RC, Stewart AF, The retinoblastoma protein, pRb, is nonessential for β-cell replication, or attainment of adult β-cell mass or function. Program of the Annual Meeting of the American Diabetes Association, Washington D.C., 2006 (Abstract, in press)
31. Paggi MG, Giordano A 2001 Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother. Cancer Res 61:4651-4654
32. Cobrinik D 2005 Pocket proteins and cell cycle control. Oncogene 24:2796-2809
33. Jiang Z, Zacksenhaus E, Gallie BL, Phillips RA 1997 The retinoblastoma gene family is differentially expressed during embryogenesis. Oncogene 14:1789-1797
34. LeCouter JE, Kablar B, Hardy WR, Ying C, Megeney LA, May LL, Rudnicki MA 1998 Strain-dependent myeloid hyperplasia, growth deficiency, and accelerated cell cycle in mice lacking the pRb-related p107 gene. Mol Cell Biol 18:7455-7465
35. LeCouter JE, Kablar B, Whyte PF, Ying C, Rudnicki MA 1998 Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development 125:4669-4679
36. An W, Kim J, Roeder RG 2004 Ordered cooperative functions of PRMT1, p300 and CARM1 in transcriptional activation by p53. Cell 117:735-748
37. Slee EA, O'Connor DJ, Lu X 2004 To die or not to die: how does p53 decide? Oncogene 23:2809-2818
38. Vousden KH, Prives C 2005 p53 and prognosis. New insights and further complexity. Cell 120:1-7
39. Knudson AG 2002 Cancer genetics. Am J Med Genet 111:96-102
40. Efrat S 1996 Genetic engineering of β-cells for cell therapy of diabetes: cell growth, function and immunogenicity. Diabet Rev 4:224-234
41. Efrat S, Linde S, Kofod H, Spector D, Delannoy M, Grant S, Hanahan D, Baekkeskov S 1988 β-Cell lines derived from transgenic mice expressing a hybrid insulin gene-oncogene. Proc Natl Acad Sci USA 85:9037-9041
42. Narushima M, Kobayashi N, Okitsu T, Tanaka Y, Li S-A, Chen Y, Miki A, Yanaka K, Nakaji S, Takei K, Soto-Gutierrez A, Rivas-Carrillo JD, Navarro-Alvarez N, Jun H-S, Westerman KA, Noguchi H, Lakey JRT, Leboulch P, Tanaka N, Yoon J-W 2005 A human β-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol 23:1274-1282
43. Tsutsui T, Hesabi B, Moons D, Pandolfi PP, Hansel KS, Koff A, Kiyokawa H 1999 Targeted disruption of cdk4 delays cell cycle entry with enhanced p27-kip activity. Mol Cell Biol 19:7011-7019
44. Martin J, Hunt SL, Dubus P, Sotillo R, Nehme-Pelluard F, Magnuson MA, Parlow AF, Malumbres M, Ortega S, Barbacid M 2003 Genetic rescue of cdk-4-null mice restores pancreatic β-cell proliferation but not homeostatic cell number. Oncogene 22:5261-5269
45. Sotillo R, Dubus P, Martin J, de la Cueva E, Ortega S, Malumbres M, Barbacid M 2001 Wide spectrum of tumors in knock-in mice carrying a cdk4 protein insensitive to INK4 inhibitors. EMBO J 20:6637-6647
46. Fatrai S, Elghazi L, Balcazar N, Cras-Meneur C, Krits I, Kiyokawa H, Bernal-Mizrachi E 2006 Akt induces β-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 55:318-325
47. Friedrichsen BN, Richter HE, Hansen JA, Rhodes CJ, Nielsen JH, Billestrup N, Moldrup A 2003 Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic β-cells. Mol Endocrinol 17:945-958
48. Imanishi Y, Hosokawa Y, Schipani E, Mallya S, Papanikolaou A, Kifor O, Tokura T, Sabolsky M, Ledgard F, Gronowicz G, Wang TC, Schmidt EV, Hall C, Brown EM, Arnold A 2001 Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest 107:1093-1102
49. Chung DC, Brown SB, Grahme-Cooke F, Seto M, Warshaw AL, Jensen RT, Arnold A 2000 Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Clin Endocrinol Metab 85:4373-4378
50. Zhang X, Gaspard JP, Mizukami Y, Li J, Graeme-Cook F, Chung DC 2005 Overexpression of cyclin D1 in pancreatic β-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes 54:712-719
51. Georgia S, Bhushan A 2004 β-Cell replication is the primary mechanism for maintaining postnatal β-cell mass. J Clin Invest 114:963-968
52. Kushner J, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, Sicinski P, White MF 2005 Cyclins D2 and D1 are essential for postnatal pancreatic β-cell growth. Mol Cell Biol 25:3752-3762
53. Moritani M, Yamasaka S, Kagami M, Suzuki T, Yamaoka T, Sano T, Hata J-I, Ikatura M 2005 Hypoplasia of endocrine and exocrine pancreas in homozygous transgenic TGF-B1. Mol Cell Endocrinol 229:175-184
54. arf. Cell 91:649-659
55. Halvorsen TL, Beattie GM, Lopez AD, Hayek A 2000 Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol 166:103-109
56. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y 2000 Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 20:6147-6158
57. Sherr CJ, Roberts JM 1999 CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512
58. kip cdk 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583
59. Kaneto H, Kajimoto Y, Fujitani Y, Matsuoka T, Sakamoto K, Matsuhisa M, Yamasaki Y, Hori M 1999 Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in β-cell dysfunction. Diabetologia 42:1093-1097
60. Maitra A, Hansel DE, Afgani P, Ashfaq R, Rahman A, Naji A, Deng S, Geradts J, Hawthorne LA, House MG, Yeo CJ 2003 Global expression analysis of well differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays. Clin Cancer Res 9:5988-5995
61. Karnick SK, Hughes CM, Gu X, Rozenblatt-Rosen O, McClean GW, Xiong Y, Meyerson M, Kim SK 2005 Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27kip1 and p18Ink4c. Proc Natl Acad Sci USA 102:14659-14664
62. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, Kido Y, Hayashi Y, Nakayama KI, White MF, Kasuga M 2005 Deletion of cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 11:175-182
63. Jetton T, Akting out signaling pathways in islet expansion. Oral Symposium, Annual Meeting of the American Diabetes Association, San Diego, CA, 2005
64. KIP2 Expression in normal islet cells and in hyperinsulinism of infancy. Diabetes 50:2763-2769
65. Bhushan A, Regulation of β-cell replication. Oral Symposium, Annual Meeting of the American Diabetes Association, San Diego, CA, 2005
66. kip2 mediates proliferative actions of PTHrP in chondrocytes. J Clin Invest 113:1334-1343
67. Stratakis CA, Marx SJ 2005 Multiple endocrine neoplasias in the era of translational medicine. Horm Metab Res 37:343-346
68. Crabtree JS, Schacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, Lorang D, Libutti SK, Chandrasekharappa SC, Marx SJ, Speigel AM, Collins FS 2001 A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 98:1118-1123
69. Crabtree JS, Scacheri PC, Ward JM, McNally SR, Swain GP, Montagna C, Hager JH, Hanahan D, Edlund H, Magnuson MA, Garrett-Beal L, Burns AL, Ried T, Chandrasekharappa SC, Marx SJ, Spiegel AM, Collins FS 2003 Of mice and MEN1: insulinomas in a conditional mouse knockout. Mol Cell Biol 23:6075-6085
70. Kozar K, Ciemerych MA, Rebel VI, Shigematsu H, Zagozdzon A, Sicinska E, Geng Y, Yu Q, Bhattacharya S, Bronson R, Akashi K, Sizinski P 2004 Mouse development and cell proliferation in the absence of D-cyclins. Cell 118:477-491
71. Malumbres M, Sotillo R, Santamaria D, Galan J, Cerezo A, Ortega S, Dubus P, Barbacid M 2004 Mammalian cell cycle without the D-type cyclin-dependent kinases cdk4 and cdk-6. Cell 118:493-504
72. Brissova M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B, Harlan DM, Powers AC 2005 Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy. J Histochem Cytochem 53:1087-1097
73. Bottino R, Balamurguran AN, Bertera S, Pietropaulo M, Trucco M, Piganelli JD 2002 Preservation of human islet cell functional mass by anti-oxidative action of a novel SOD mimic compound. Diabetes 51:2561-2567
74. Shapiro AMJ, Lakey JRT, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV 2000 Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238
75. Laybutt DR, Weir GC, Kaneto H, Lebet J, Palmiter RD, Sharma A, Bonner-Weir S 2002 Overexpression of c-myc in β-cells of transgenic mice causes proliferation and apoptosis, downregulation of insulin gene expression, and diabetes. Diabetes 51:1793-1804
76. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell M, Weinberg RA 1992 Effects of an Rb mutation in the mouse. Nature 359:295-300
77. Check E 2004 Gene therapists hopeful as trials resume with childhood disease. Nature 429:587
78. Rhodes CJ 2000 IGF-I and GH post-receptor signaling mechanisms for pancreatic β-cell replication. J Mol Endocrinol 24:303-311
79. Stout LE, Svensson AM, Sorenson RL 1997 Prolactin regulation of islet-derived INS-1 cells: characteristics and immunocytochemical analysis of STAT5 translocation. Endocrinology 138:1592-1603
80. Sorenson RL, Brelje TC 1997 Adaptation of islets of Langerhans to pregnancy: β-cell growth, enhanced insulin secretion and the role of lactogenic hormones. Horm Metab Res 29:301-307
81. Garcia-Ocana A, Vasavada RC, Cebrian A, Reddy V, Takane KK, Lopez-Talavera JC, Stewart AF 2001 Transgenic overexpression of hepatocyte growth factor in the β-cell markedly improves islet function and islet transplant outcomes in mice. Diabetes 50:2752-2762
82. Kulkarni RN, Bruning JC, Winnay JN, Postic C, Magnuson MA, Kahn CR 1999 Tissue-specific knockout of the insulin receptor in pancreatic β-cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 96:329-339
83. Li FX, Zhu JW, Tessem JS, Beilke J, Varella-Garcia M, Jensen J, Hogan CJ, DeGregori J 2003 The development of diabetes in E2F1/ E2F2 mutant mice reveals important roles for bone marrow derived cells in preventing islet loss. Proc Natl Acad Sci USA 100:12935-12940
84. Goodrich DW 2003 How the other half lives, the amino-terminal domain of the retinoblastoma tumor suppressor protein. J Cell Physiol 197:169-180
85. Barrientes S, Cooke C, Goodrich DW 2000 Glutamic acid mutagenesis of retinoblastoma protein phosphorylation sites has diverse effects on function. Oncogene 19:562-570